4962 Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94
    ATCC l acidophilus atcc 4962
    L Acidophilus Atcc 4962, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/l acidophilus atcc 4962/product/ATCC
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    l acidophilus atcc 4962 - by Bioz Stars, 2023-02
    94/100 stars
      Buy from Supplier

    90
    ATCC m wahieum y12t 1⁄4 atcc
    M Wahieum Y12t 1⁄4 Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/m wahieum y12t 1⁄4 atcc/product/ATCC
    Average 90 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    m wahieum y12t 1⁄4 atcc - by Bioz Stars, 2023-02
    90/100 stars
      Buy from Supplier

    93
    Tocris sb 204990
    (A) Representative Western blot and quantification of phosphorylated SMAD2 (pSMAD2) in the presence or absence of the TGFβ signaling inhibitor SB431542 following control or CPT1A knockdown (n=3 independent experiments). (B) Levels of acetyl-CoA in control or cytokine-treated endothelial cells (n=3 independent experiments). (C) Cytosolic acetyl-CoA levels can be increased by ACSS2-mediated acetate conversion or reduced by the ACLY chemical inhibitor <t>SB-204990.</t> ACLY, ATP citrate lyase; ACSS2, acyl-coenzyme A synthetase short-chain family member 2. (D) Acetate treatment inhibits cytokine-induced pSMAD2 (n=3 independent experiments). (E) Acetate treatment inhibits EndoMT (technical triplicates per condition, data are representative of one of three independent experiments). (F) Acetate treatment inhibits cytokine-induced EndoMT protein expression. (G) SB-204990 induces EndoMT (technical triplicates per condition, data represents one of three independent experiments). (H and I) Western blot analysis of wildtype SMAD7 protein levels with or without acetate or SB204990 (H) or expression of the K64/70A acetylation-defective SMAD7 mutant under these same conditions (I) (n=3 independent experiments). Data represents mean ± SEM, with significance determined by one-way ANOVA with Bonferroni’s multiple comparison test (A, D, E, H, I). * p < 0.05; ** p < 0.01; ns, not significant.
    Sb 204990, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sb 204990/product/Tocris
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    sb 204990 - by Bioz Stars, 2023-02
    93/100 stars
      Buy from Supplier

    86
    Bruker Corporation data collection bruker smart ccd area detector diffractometer 4962 reflections
    (A) Representative Western blot and quantification of phosphorylated SMAD2 (pSMAD2) in the presence or absence of the TGFβ signaling inhibitor SB431542 following control or CPT1A knockdown (n=3 independent experiments). (B) Levels of acetyl-CoA in control or cytokine-treated endothelial cells (n=3 independent experiments). (C) Cytosolic acetyl-CoA levels can be increased by ACSS2-mediated acetate conversion or reduced by the ACLY chemical inhibitor <t>SB-204990.</t> ACLY, ATP citrate lyase; ACSS2, acyl-coenzyme A synthetase short-chain family member 2. (D) Acetate treatment inhibits cytokine-induced pSMAD2 (n=3 independent experiments). (E) Acetate treatment inhibits EndoMT (technical triplicates per condition, data are representative of one of three independent experiments). (F) Acetate treatment inhibits cytokine-induced EndoMT protein expression. (G) SB-204990 induces EndoMT (technical triplicates per condition, data represents one of three independent experiments). (H and I) Western blot analysis of wildtype SMAD7 protein levels with or without acetate or SB204990 (H) or expression of the K64/70A acetylation-defective SMAD7 mutant under these same conditions (I) (n=3 independent experiments). Data represents mean ± SEM, with significance determined by one-way ANOVA with Bonferroni’s multiple comparison test (A, D, E, H, I). * p < 0.05; ** p < 0.01; ns, not significant.
    Data Collection Bruker Smart Ccd Area Detector Diffractometer 4962 Reflections, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/data collection bruker smart ccd area detector diffractometer 4962 reflections/product/Bruker Corporation
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    data collection bruker smart ccd area detector diffractometer 4962 reflections - by Bioz Stars, 2023-02
    86/100 stars
      Buy from Supplier

    Image Search Results


    (A) Representative Western blot and quantification of phosphorylated SMAD2 (pSMAD2) in the presence or absence of the TGFβ signaling inhibitor SB431542 following control or CPT1A knockdown (n=3 independent experiments). (B) Levels of acetyl-CoA in control or cytokine-treated endothelial cells (n=3 independent experiments). (C) Cytosolic acetyl-CoA levels can be increased by ACSS2-mediated acetate conversion or reduced by the ACLY chemical inhibitor SB-204990. ACLY, ATP citrate lyase; ACSS2, acyl-coenzyme A synthetase short-chain family member 2. (D) Acetate treatment inhibits cytokine-induced pSMAD2 (n=3 independent experiments). (E) Acetate treatment inhibits EndoMT (technical triplicates per condition, data are representative of one of three independent experiments). (F) Acetate treatment inhibits cytokine-induced EndoMT protein expression. (G) SB-204990 induces EndoMT (technical triplicates per condition, data represents one of three independent experiments). (H and I) Western blot analysis of wildtype SMAD7 protein levels with or without acetate or SB204990 (H) or expression of the K64/70A acetylation-defective SMAD7 mutant under these same conditions (I) (n=3 independent experiments). Data represents mean ± SEM, with significance determined by one-way ANOVA with Bonferroni’s multiple comparison test (A, D, E, H, I). * p < 0.05; ** p < 0.01; ns, not significant.

    Journal: Molecular cell

    Article Title: A Metabolic Basis for Endothelial-to-Mesenchymal Transition

    doi: 10.1016/j.molcel.2018.01.010

    Figure Lengend Snippet: (A) Representative Western blot and quantification of phosphorylated SMAD2 (pSMAD2) in the presence or absence of the TGFβ signaling inhibitor SB431542 following control or CPT1A knockdown (n=3 independent experiments). (B) Levels of acetyl-CoA in control or cytokine-treated endothelial cells (n=3 independent experiments). (C) Cytosolic acetyl-CoA levels can be increased by ACSS2-mediated acetate conversion or reduced by the ACLY chemical inhibitor SB-204990. ACLY, ATP citrate lyase; ACSS2, acyl-coenzyme A synthetase short-chain family member 2. (D) Acetate treatment inhibits cytokine-induced pSMAD2 (n=3 independent experiments). (E) Acetate treatment inhibits EndoMT (technical triplicates per condition, data are representative of one of three independent experiments). (F) Acetate treatment inhibits cytokine-induced EndoMT protein expression. (G) SB-204990 induces EndoMT (technical triplicates per condition, data represents one of three independent experiments). (H and I) Western blot analysis of wildtype SMAD7 protein levels with or without acetate or SB204990 (H) or expression of the K64/70A acetylation-defective SMAD7 mutant under these same conditions (I) (n=3 independent experiments). Data represents mean ± SEM, with significance determined by one-way ANOVA with Bonferroni’s multiple comparison test (A, D, E, H, I). * p < 0.05; ** p < 0.01; ns, not significant.

    Article Snippet: For chemical induction of EndoMT, subconfluent endothelial cells on fibronectin-coated 6-well plates were incubated with the ACLY inhibitor, SB-204990 (Tocris) at final concentration of 60 µM or with a mitochondrial citrate transport protein (CTP) inhibitor (Sigma-Aldrich) at a final concentration of 1 mM.

    Techniques: Western Blot, Expressing, Mutagenesis